A Modified Epirubicin and Oxaliplatin Plus Capecitabine (EOX) Regimen as a Second- Line Therapy in Patients with Advanced Gastric Cancer
about
A Modified Epirubicin and Oxaliplatin Plus Capecitabine (EOX) Regimen as a Second- Line Therapy in Patients with Advanced Gastric Cancer
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
A Modified Epirubicin and Oxal ...... s with Advanced Gastric Cancer
@en
A Modified Epirubicin and Oxaliplatin Plus Capecitabine
@nl
type
label
A Modified Epirubicin and Oxal ...... s with Advanced Gastric Cancer
@en
A Modified Epirubicin and Oxaliplatin Plus Capecitabine
@nl
prefLabel
A Modified Epirubicin and Oxal ...... s with Advanced Gastric Cancer
@en
A Modified Epirubicin and Oxaliplatin Plus Capecitabine
@nl
P2093
P2860
P1476
A Modified Epirubicin and Oxal ...... s with Advanced Gastric Cancer
@en
P2093
Alican Kurtipek
Gökmen Umut Erdem
Nebi Serkan Demirci
Nuriye Yıldırım Özdemir
Nurullah Zengin
Ozan Yazıcı
Yakup Bozkaya
P2860
P304
P356
10.22034/APJCP.2018.19.1.283
P50
P577
2018-01-27T00:00:00Z